-
Notifications
You must be signed in to change notification settings - Fork 13
update Preregistration templates #30
New issue
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.
By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.
Already on GitHub? Sign in to your account
base: master
Are you sure you want to change the base?
Changes from 17 commits
5722846
3de1aa5
0fa3050
b69f57d
5ceaa9b
322ade9
f63b6b3
5c9037d
378b6e3
41b633a
71fad36
23371b7
26dd71f
b21300d
dfe2560
bb23ead
1020af5
3c05894
f1f7674
6f7d664
7d3af5c
a5eb61e
6719857
beea500
bf1da1e
979cf22
85c4b21
8368b78
44d0af4
9c87b80
bdf2b93
a610e55
39953b1
1b32cee
cf00400
b7354c4
f1ba6c1
c2a43d4
25a3c42
f4df755
b6b60fa
6ecae6e
7b481a0
941a91b
5c7b7bf
File filter
Filter by extension
Conversations
Jump to
Diff view
Diff view
There are no files selected for viewing
Large diffs are not rendered by default.
Large diffs are not rendered by default.
| Original file line number | Diff line number | Diff line change |
|---|---|---|
| @@ -0,0 +1,175 @@ | ||
| --- | ||
| title : "Preregistration Template for Scoping Reviews" | ||
| shorttitle : "My preregistration" | ||
| date : "`r Sys.setlocale('LC_TIME', 'C'); format(Sys.time(), '%d\\\\. %B %Y')`" | ||
|
|
||
| author: | ||
| - name : First Author | ||
| affiliation : 1 | ||
| - name : Second Author | ||
| affiliation : "1,2" | ||
|
|
||
| affiliation: | ||
| - id : 1 | ||
| institution : First institution | ||
| - id : 2 | ||
| institution : Second institution | ||
|
|
||
| output: prereg::prereg_pdf | ||
| --- | ||
|
|
||
| ```{r setup, include=FALSE} | ||
| knitr::opts_chunk$set(echo = TRUE) | ||
| ``` | ||
|
|
||
| # Title | ||
|
|
||
|
|
||
| ## Contributors, Affiliations, and Persistent IDs (recommend ORCID iD) | ||
| <!--Provide in separate entries the full name of each contributor, each contributor's professional affiliation, and each contributor's persistent ID. See ORCID iD for an example of persistent ID (https://orcid.org/). Optional: include the intended contribution of each person listed (e.g. conceptualization, data collection; see CRediT, https://casrai.org/credit/).--> | ||
| Enter your response here | ||
|
|
||
| ## Date of Preregistration | ||
| <!--This is assigned by the system upon preregistration submission.--> | ||
| Enter your response here | ||
|
|
||
| ## Project stage at registration | ||
| <!--Describe what steps of project planning have already been completed and what the current status of the project is at the time of preregistration.--> | ||
| Enter your response here | ||
|
|
||
| ## Anticipated start date | ||
| <!--Indicate the approximate time when data gathering for the scoping review is scheduled to begin.--> | ||
| Enter your response here | ||
|
|
||
| ## Estimated duration of project | ||
| <!--Include best estimate for how long the project will take from preregistration submission to project completion.--> | ||
| Enter your response here | ||
|
|
||
| ## Optional: IRB Status | ||
| <!--If appropriate institutional approval has been obtained for the study, provide the relevant identifier here. If the study will be exempt from ethical board review, provide reasoning here.--> | ||
| Enter your response here | ||
|
|
||
| ## Conflict of Interest Statement | ||
| <!--Identify any real or perceived conflicts of interest with this review. For example, any interests or activities that might be seen as influencing the research (e.g., financial interests in a test or procedure, funding by pharmaceutical companies for research).--> | ||
| Enter your response here | ||
|
|
||
| ## Keywords | ||
| <!--Include terms specific to your topic, methodology, and population. Use natural language and avoid words used in the title or overly general terms. If you need help with keywords, try a keyword search using your proposed keywords in a search engine to check results.--> | ||
| Enter your response here | ||
|
|
||
| ## Data accessibility statement and planned repository | ||
| <!--"We plan to make the data available (yes / no) | ||
|
||
| If "yes", please specify the planned data availability level by selecting one of the options:--> | ||
| * Data access via download; usage of data for all purposes (public use file) | ||
| * Data access via download; usage of data restricted to scientific purposes (scientific use file) | ||
| * Data access via download; usage of data has to be agreed and defined on an | ||
| individual case basis | ||
| * Data access via secure data center (no download, usage/analysis only in a secure | ||
| data center) | ||
| * Data available upon email request by member of scientific community | ||
| * Other (please specify)--> | ||
|
|
||
|
|
||
| ## Optional: Code availability | ||
| <!--We plan to make the code available (yes / no). | ||
| If "yes", please specify the planned code availability level (use same descriptors of data in T10).--> | ||
| Enter your response here | ||
|
|
||
| ## Optional: Standard lab practices | ||
| <!--Standard lab practices refer to a (timestamped) document, software package, or similar, which specifies standard pipelines, analytical decisions, etc. which always apply to certain types of research in a lab. Specify here and refer to at the appropriate positions in the remainder of the template: | ||
| We plan to make the standard lab practices available (yes / no). | ||
| If "yes", please specify the planned standard lab practices availability level (use same descriptors of data in T10).--> | ||
| Enter your response here | ||
|
|
||
| ## Funding | ||
| <!--Describe sources of funding for the included sources of evidence, as well as sources of funding for the scoping review. Describe the role of the funders of the scoping review.--> | ||
| Enter your response here | ||
|
|
||
|
|
||
| # Abstract | ||
|
|
||
| ## Structured summary | ||
| <!--Provide a structured summary that includes (as applicable): background, objectives, eligibility criteria, sources of evidence, and charting methods that relate to the review questions and objectives.--> | ||
| Enter your respone here | ||
|
|
||
|
|
||
| # Introduction | ||
|
|
||
|
|
||
| ## Rationale | ||
| <!--Describe the rationale for the review in the context of what is already known. Explain why the review questions/objectives lend themselves to a scoping review approach.--> | ||
| Enter your respone here | ||
|
|
||
| ## Objectives | ||
| <!--Provide an explicit statement of the questions and objectives being addressed with reference to their key elements (e.g., population or participants, concepts, and context) or other relevant key elements used to conceptualize the review questions and/or objectives.--> | ||
| Enter your respone here | ||
|
|
||
|
|
||
| # Methods | ||
|
|
||
| ## Eligibility criteria | ||
| <!--Specify characteristics of the sources of evidence that will be used as eligibility criteria (e.g., years considered, language, and publication status), and provide a rationale.--> | ||
| Enter your respone here | ||
|
|
||
| ## Information sources | ||
| <!--*Where sources of evidence are compiled from, such as bibliographic databases, social media platforms, and Web sites. | ||
|
||
| Describe all information sources in the search (e.g., databases with dates of coverage and contact with authors to identify additional sources), as well as the date the most recent search was executed--> | ||
| Enter your respone here | ||
|
|
||
| ## Search | ||
| <!--Present the full electronic search strategy for at least 1 database, including any limits that will be used, such that it could be repeated.--> | ||
| Enter your respone here | ||
|
|
||
| ## Selection of sources of evidence | ||
| <!--*A more inclusive/heterogeneous term used to account for the different types of evidence or data sources (e.g., quantitative and/or qualitative research, expert opinion, and policy documents) that may be eligible in a scoping review as opposed to only studies. This is not to be confused with information sources. | ||
| State the process for selecting sources of evidence (i.e., screening and eligibility) included in the scoping review.--> | ||
| Enter your respone here | ||
|
|
||
| # Data charting process | ||
| <!--*The frameworks by Arksey and O’Malley ( | ||
|
||
| ) and Levac and colleagues ( | ||
| guidance ( | ||
| process of data extraction in a scoping review as data charting. | ||
| ) and the JBI ) refer to the | ||
| Scoping studies: towards a methodological framework. Int | ||
| J Soc Res Methodol. 2005;8:19-32. | ||
| Scoping studies: advancing the | ||
| methodology. Implement Sci. 2010;5:69. [PMID: 20854677] doi:10.1186/1748-5908-5-69 | ||
| Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13:141-6. | ||
| [PMID: 26134548] doi:10.1097/XEB.0000000000000050 | ||
| ; | ||
| Scoping reviews. In: Aromataris E, Munn Z, eds. | ||
| Joanna Briggs Institute Reviewer's Manual. Adelaide, Australia: Joanna Briggs Inst; 2017. | ||
| Describe the methods of charting data from the included sources of evidence (e.g., calibrated forms or forms that have been tested by the team before their use, and whether data charting will be done independently or in duplicate) and any processes for obtaining and confirming data from investigators.--> | ||
| Enter your respone here | ||
|
|
||
| ## Data items | ||
| <!--List and define all variables for which data will be sought and any assumptions and simplifications that will be made.--> | ||
| Enter your respone here | ||
|
|
||
| ## Critical appraisal of individual sources of evidence | ||
| <!--*The process of systematically examining research evidence to assess its validity, results, and relevance before using it to inform a decision. This term is used for this item instead of "risk of bias" (which is more applicable to systematic reviews of interventions) to include and acknowledge the various sources of evidence that may be used in a scoping review (e.g., quantitative and/or qualitative research, expert opinion, and policy document). | ||
| If done, provide a rationale for conducting a critical appraisal of included sources of evidence; describe the methods that will be used and how this information will be used in any data synthesis (if appropriate).--> | ||
| Enter your respone here | ||
|
|
||
| ## Synthesis of results | ||
| <!--Describe the methods of handling and summarizing the data that will be charted.--> | ||
| Enter your respone here | ||
|
|
||
|
|
||
| # Other information optional | ||
| <!--(NOTE: If needed, multiple lines with other information can be included)--> | ||
|
|
||
|
|
||
| ## Other information | ||
| <!--If there is any additional information that you feel needs to be included in your preregistration, please enter it here. Literature cited, disclosures of any related work such as replications or work that uses the same data, or other context that will be helpful for future readers would be appropriate here.--> | ||
| Enter your respone here | ||
|
|
||
|
|
||
| # References | ||
| ## | ||
| \vspace{-2pc} | ||
| \setlength{\parindent}{-0.5in} | ||
| \setlength{\leftskip}{-1in} | ||
| \setlength{\parskip}{8pt} | ||
| \noindent | ||
There was a problem hiding this comment.
Choose a reason for hiding this comment
The reason will be displayed to describe this comment to others. Learn more.
This code chunk can be removed.